Recombinant Anti-SET3 antibody [EPR20101] (ab202434)
![Western blot - Anti-SET3 antibody [EPR20101] (ab202434)](https://www.abcam.com/ps/products/202/ab202434/Images/ab202434-292980-anti-set3-antibody-epr20101-western-blot.jpg "Western blot - Anti-SET3 antibody [EPR20101] (ab202434)")
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR20101] to SET3
- Suitable for: WB
- Knockout validated
- Reacts with: Saccharomyces cerevisiae
Related conjugates and formulations
Overview
-
Product name
Anti-SET3 antibody [EPR20101]
See all SET3 primary antibodies -
Description
Rabbit monoclonal [EPR20101] to SET3 -
Host species
Rabbit -
Tested applications
Suitable for: WBmore details -
Species reactivity
Reacts with: Saccharomyces cerevisiae -
Immunogen
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: Saccharomyces cerevisiae whole cell lysate.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: PBS, 0.05% BSA, 40% Glycerol (glycerin, glycerine) -
Concentration information loading... -
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR20101 -
Isotype
IgG
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab202434 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB |
1/2000. Detects a band of approximately 85 kDa (predicted molecular weight: 85 kDa).
|
| Notes |
|---|
|
WB
1/2000. Detects a band of approximately 85 kDa (predicted molecular weight: 85 kDa). |
Images
-
Western blot - Anti-SET3 antibody [EPR20101] (ab202434)Anti-SET3 antibody [EPR20101] (ab202434) at 1/2000 dilution + Saccharomyces cerevisiae whole cell lysate at 10 µg
Secondary
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 85 kDa
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
-
![Western blot - Anti-SET3 antibody [EPR20101] (ab202434)](https://www.abcam.com/ps/products/202/ab202434/Images/ab202434-292979-anti-set3-antibody-epr20101-western-blot.jpg)
Western blot - Anti-SET3 antibody [EPR20101] (ab202434)All lanes : Anti-SET3 antibody [EPR20101] (ab202434) at 1/1000 dilution
Lane 1 : Saccharomyces cerevisiae (WT) whole cell lysate
Lane 2 : Saccharomyces cerevisiae (SET3 KO) whole cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 85 kDa
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
KO strain (Y07046) was purchased from Euroscarf.
-
![Anti-SET3 antibody [EPR20101] (ab202434)](https://www.abcam.com/ps/products/202/ab202434/Images/ab202434-4-benefits-of-recombinant-antibodies.png)
Anti-SET3 antibody [EPR20101] (ab202434)
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
Certificate of Compliance
References (0)
ab202434 has not yet been referenced specifically in any publications.